More recently, some breast cancer cell lines have been shown to activate Src in response to TRAIL treatment24 and it is thought this may be a mechanism of acquired TRAIL resistance, as a concomitant increase in caspase-8 phosphorylation was observed. This evidence concerns the gene SRC and breast carcinoma.